Drug intelligence / Profile preview

Leptin A-200

Development stage
Phase 1
Lead developer
Bristol Myers Squibb
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

Leptin A-200 is a long-acting engineered form of recombinant human leptin (Fc-leptin), designed for weekly dosing. It is a protein hormone analog that mimics endogenous leptin, which is primarily produced by adipose tissue and regulates energy balance by suppressing appetite through hypothalamic pathways. Leptin acts via the leptin receptor (Ob-Rb), activating JAK-STAT and MAPK signaling to reduce food intake and modulate metabolism. Leptin A-200 was developed as an anti-obesity agent but was not effective in producing significant weight loss in clinical trials compared to placebo or other agents such as caffeine/ephedrine[1][4][8]. The drug has also been studied for its effects on fat mass and metabolic parameters but did not show significant benefit over controls.

Other names
leptin A-200recombinant methionyl human Fc-leptin
02

Targets

LEPR (Leptin receptor)

Beyond the preview

Go deeper on Leptin A-200.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leptin A-200.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call